Dummer R - Search Results

1

Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant Melanoma.

Matter AV, Micaletto S, Urner-Bloch U, Dummer R, Goldinger SM. Matter AV, et al. Among authors: dummer r. Oncologist. 2020 Nov;25(11):e1593-e1597. doi: 10.1634/theoncologist.2019-0656. Epub 2020 Sep 21. Oncologist. 2020. PMID: 32886824 Free PMC article.

2

Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris.

Goldinger SM, Dummer R, Schmid P, Prinz Vavricka M, Burg G, Lauchli S. Goldinger SM, et al. Among authors: dummer r. Dermatology. 2006;213(2):134-9. doi: 10.1159/000093852. Dermatology. 2006. PMID: 16902290 Clinical Trial.

3

Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.

Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S. Goldinger SM, et al. Among authors: dummer r. J Eur Acad Dermatol Venereol. 2007 Apr;21(4):504-8. doi: 10.1111/j.1468-3083.2006.02016.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17373978 Clinical Trial.

4

Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.

Strobel K, Bode B, Dummer R, Veit-Haibach P, Fischer DR, Imhof L, Goldinger S, Steinert HC, von Schulthess GK. Strobel K, et al. Among authors: dummer r. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1774-82. doi: 10.1007/s00259-009-1175-0. Epub 2009 Jun 4. Eur J Nucl Med Mol Imaging. 2009. PMID: 19495748

5

[Current therapy of carcinoma of the skin].

Dummer R, Goldinger SM, Sailer E, French LE. Dummer R, et al. Ther Umsch. 2010 Sep;67(9):447-52. doi: 10.1024/0040-5930/a000078. Ther Umsch. 2010. PMID: 20806173 Review. German.

6

The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.

Imhof L, Goldinger SM, Baumann K, Schad K, French LE, Röthlisberger P, Dummer R. Imhof L, et al. Among authors: dummer r. Melanoma Res. 2011 Feb;21(1):80-3. doi: 10.1097/CMR.0b013e328341442d. Melanoma Res. 2011. PMID: 21052029 Clinical Trial.

7

A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status.

Zipser MC, Eichhoff OM, Widmer DS, Schlegel NC, Schoenewolf NL, Stuart D, Liu W, Gardner H, Smith PD, Nuciforo P, Dummer R, Hoek KS. Zipser MC, et al. Among authors: dummer r. Pigment Cell Melanoma Res. 2011 Apr;24(2):326-33. doi: 10.1111/j.1755-148X.2010.00823.x. Epub 2011 Jan 12. Pigment Cell Melanoma Res. 2011. PMID: 21176117

8

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07).

von Moos R, Seifert B, Simcock M, Goldinger SM, Gillessen S, Ochsenbein A, Michielin O, Cathomas R, Schläppi M, Moch H, Schraml PH, Mjhic-Probst D, Mamot C, Schönewolf N, Dummer R; Swiss Group for Clinical Cancer Research (SAKK). von Moos R, et al. Among authors: dummer r. Ann Oncol. 2012 Feb;23(2):531-6. doi: 10.1093/annonc/mdr126. Epub 2011 Apr 28. Ann Oncol. 2012. PMID: 21527587 Free article. Clinical Trial.

9

Cutaneous lymphomas: molecular pathways leading to new drugs.

Dummer R, Goldinger SM, Cozzio A, French LE, Karpova MB. Dummer R, et al. J Invest Dermatol. 2012 Mar;132(3 Pt 1):517-25. doi: 10.1038/jid.2011.370. Epub 2011 Dec 8. J Invest Dermatol. 2012. PMID: 22158559 Free article. Review.

10

Ultraviolet A and photosensitivity during vemurafenib therapy.

Dummer R, Rinderknecht J, Goldinger SM. Dummer R, et al. N Engl J Med. 2012 Feb 2;366(5):480-1. doi: 10.1056/NEJMc1113752. N Engl J Med. 2012. PMID: 22296092 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

996 results

Search Page